EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Nephronophthisis: Current clinical spectrum and molecular pathogenesis

Ya Li iD, Siwei Yang iD, Xiying Chen iD, Jianhua Mao iD, Shanshan Xie iD

The FEBS Journal · 2026-07-04

DOI: 10.1111/febs.70646 ↗

At a glance

Übersichtsarbeit in The FEBS Journal, published online on 2026-07-04. Written by Ya Li and 4 co-authors. Institution: Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Han…. Major MEDLINE topics: Kidney Diseases, Cystic, Kidney Failure, Chronic. 62 references. Funded by: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Nephronophthisis (NPH) is a ciliopathy primarily affecting renal tubules and interstitial tissue, ultimately progressing to end‐stage kidney disease (ESKD). The clinical spectrum of NPH is broad and can be classified according to the age at onset into infantile, juvenile, adolescent, and late‐onset forms. Histopathologically, NPH is characterized by corticomedullary cysts, tubular atrophy, interstitial fibrosis, and cystic dilatation of distal tubules. The kidneys may appear normal in early stages but gradually shrink with disease progression. More than 20 causative genes have been identified, with NPHP1 being the most common. These genes encode proteins that localize predominantly to the ciliary transition zone and basal body, where they regulate ciliary structure and signaling. Loss of ciliary function disrupts epithelial polarity, intracellular trafficking, and signal transduction, leading to tubular injury and fibrosis. When extrarenal organs such as the retina, liver, or central nervous system are affected, the condition is defined as nephronophthisis‐related ciliopathies (NPH‐RC). This review summarizes the current understanding of NPH classification, clinical features, and molecular mechanisms. Here, we highlighted recent advances in genetic discoveries, pathogenic signaling pathways, and therapeutic strategies, including gene therapy and targeted molecular interventions.

Subjects

MeSH terms (MEDLINE)

Kidney Diseases, CysticKidney Failure, ChronicHumansCiliaAdaptor Proteins, Signal TransducingAnimalsSignal TransductionMutationMembrane ProteinsCytoskeletal Proteins

Author keywords

CiliopathyGenetic pathogenesisKidney diseaseNephronophthisisPrimary cilia

Substances

NPHP1 protein, humanAdaptor Proteins, Signal TransducingMembrane ProteinsCytoskeletal Proteins

Authors and institutions

  • Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou, China.
  • Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.
  • Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID profiles: Ya Li, Siwei Yang, Xiying Chen, Jianhua Mao, Shanshan Xie

Funding

  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Cite

APA

Li, Y., Yang, S., Chen, X., Mao, J., & Xie, S. (2026). Nephronophthisis: Current clinical spectrum and molecular pathogenesis. The FEBS Journal. https://doi.org/10.1111/febs.70646

Vancouver

Li Y, Yang S, Chen X, Mao J, Xie S. Nephronophthisis: Current clinical spectrum and molecular pathogenesis. The FEBS Journal. 2026. doi:10.1111/febs.70646

BibTeX
@article{Li2026,
  author = {Li, Ya and Yang, Siwei and Chen, Xiying and Mao, Jianhua and Xie, Shanshan},
  title = {Nephronophthisis: Current clinical spectrum and molecular pathogenesis},
  journal = {The FEBS Journal},
  year = {2026},
  doi = {10.1111/febs.70646}
}
Start for free →